CEO WAS ‘BRO’W BEATEN

Shkreli ‘threats’

“Pharma Bro” Martin Shkreli “went on a warpath’’ when his company moved to oust him, threatening his replacement’s family and breaking into the firm’s offices to swipe files, according to testimony Friday.

“I had never dealt with anyone like this,’’ said Stephen Aselage, the CEO who replaced him at the drug company Retrophin.

Aselage told Brooklyn federal-court jurors that Retrophin’s board members were getting sick and tired of Shkreli’s (inset) antics — which included hiring private eyes to spy on underlings,

Shkreli, 34, was asked to step down in September 2014, but he refused — and that’s when things got really nasty, Aselage said.

“He said I would regret my actions, there would be waves of litigation and I and my family would suffer as a result of my actions,” Aselage said.

Shkreli — who became “the most hated man in America’’ for jacking up the price of a lifesaving AIDS drug from $13.50 per pill to $750 — set out to “damage the company,” Aselage said.

Board members had been concerned by Shkreli’s increasingly erratic behavior, including tweets he sent that “tended to be immature and not particularly appropriate,” the CEO said.

“I saw them as a distraction. Other board members saw them as more than a distraction,” he said.

One of the more worrisome tweets came in 2014, when Shkreli announced that “this was the best day of his life” during trading hours, Aselage said.

“This started a back-andforth with followers who were asking, ‘Should I buy stock?’ ” Aselage testified. “The implication was he was giving trading tips based on non-public information.”

Retrophin’s board eventually reached an agreement with Shkreli in which the company would divest three of its pharmaceuticals to his new company in exchange for his resignation and $3 million, Aselage said.

Shkreli is on trial for allegedly using money from Retrophin and his other drug companies to pay off investors in his failed hedge fund MSMB Capital after making bad investments.